Elanco Animal Health (ELAN) Research & Development (2017 - 2026)

Elanco Animal Health (ELAN) has 10 years of Research & Development data on file, last reported at $97.0 million in Q1 2026.

• For the quarter ending Q1 2026, Research & Development rose 3.19% year-over-year to $97.0 million; the trailing twelve-month figure through Mar 2026 stood at $371.0 million (up 5.7% YoY), and the FY2025 full-year result was $368.0 million, up 6.98% from the prior year.
• Research & Development grew to $97.0 million in Q1 2026, from $93.0 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $97.0 million in Q1 2026 to a low of $78.0 million in Q3 2022.
• A 5-year average of $85.7 million and a median of $86.0 million in 2023 frame the typical range for Research & Development.
• Across the five-year window, Research & Development decreased 17.02% in 2022 and advanced 14.81% in 2025, its largest moves.
• Tracing ELAN's Research & Development over 5 years: stood at $80.0 million in 2022, then slipped by 1.25% to $79.0 million in 2023, then grew by 2.53% to $81.0 million in 2024, then increased by 14.81% to $93.0 million in 2025, then climbed by 4.3% to $97.0 million in 2026.
• Business Quant data shows ELAN's Research & Development at $97.0 million in Q1 2026, $93.0 million in Q4 2025, and $89.0 million in Q3 2025.